Effectiveness of Asthma Inhaler Pharmacotherapy must take into consideration both the device and drug and which is guided by clinically meaningful outcomes
Journal: Archives of Pulmonology and Respiratory Care (Vol.3, No. 2)Publication Date: 2017-06-09
Authors : Elissa M McDonald; Felix SF Ram;
Page : 044-047
Keywords : ;
Abstract
Introduction: The inhalation route remains the mainstay of therapy for asthma and chronic obstructive pulmonary disease (COPD). This confers a number of advantages such as delivery of medication directly to the site of action resulting in faster onset. It also allows smaller doses to be administered and therefore significantly reduces systemic side effects compared with oral therapy. The drug treatment regime for the majority of patients with asthma and COPD is straightforward and is documented in many guidelines [1-3]. However, the choice of which inhaler device to use is less straightforward. Rather than being spoilt for choice, we are frequently confused by the ever-increasing number of devices available. Although inhalation therapy is now the mainstay of asthma treatment, for most patients such treatment is still not optimal.
Other Latest Articles
- Hypoxia/Reoxygenation modulates Oxidative Stress Level and Antioxidative Potential in Lung Mitochondria: Possible participation of P53 and NF-KB Target Proteins
- What do we have to know about Cystic Lung Diseases?
- Mucin Production Correlates with Dual Expression of Epidermal Growth Factor Receptor and Its Ligand the Epidermal Growth Factor in Non-Small Cell Lung Cancer
- Impact of Calorie Intakes on the Risk of Bronchopulmonary Dysplasia in Extremely Preterm Infants
- Inhaled GM-CSF in a Pulmonary Alveolar Proteinosis Patient Refractory to Plasmapheresis Combined with Multiple Whole Lung Lavages
Last modified: 2018-10-01 18:22:06